Please login to the form below
Diabetes prevention
This page shows the latest Diabetes prevention news and features for those working in and with pharma, biotech and healthcare.
Sanofi to acquire Provention Bio in deal worth $2.9bn
The merger includes recently-approved type 1 diabetes prevention therapy Tzield. Sanofi has announced that it will acquire US-based Provention Bio for $2.9bn, strengthening the French drugmaker’s portfolio ... Through the acquisition, Sanofi will gain
Latest news
-
Eli Lilly and EVA Pharma collaborate to enhance insulin access in Africa
type 2 diabetes in low- to middle-income countries (LMICs), most of which are in Africa. ... Last year, the World Health Organization (WHO) established the Global Diabetes Compact, a global initiative to support countries in implementing effective
-
FDA rejects Provention Bio’s type 1 diabetes prevention drug
The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) denying approval for Provention Bio’s type 1 diabetes (T1D) prevention drug teplizumab.
-
FDA panel backs Provention Bio’s type 1 prevention drug teplizumab
A US Food and Drug Administration (FDA) panel has voted in favour of Provention Bio’s type 1 diabetes prevention drug teplizumab, setting it up for a potential approval in July. ... Compared to placebo, children and adults who were considered high-risk
-
Best practice in UK diabetes celebrated at virtual QiC Diabetes Awards 2020
by Cwm Taf Morgannwg University Health Board. 6. Diabetes Education Programmes – Healthcare Professionals. ... by The Paula Carr Diabetes Charitable Trust. 8. Prevention, Remission and Early Diagnosis.
-
World Diabetes Day 2019
The findings coincide with World Diabetes Day, a global awareness campaign focused on diabetes mellitus. ... Diabetes is a chronic condition, and is a leading cause of blindness, lower-limb amputation, cardiovascular disease and kidney failure.
More from news
Approximately 1 fully matching, plus 34 partially matching documents found.
Latest Intelligence
-
The rising prevalence of diabetes in Europe
Added to this is the unexplained increase of type 1 diabetes in children. ... The network wants to see action on several fronts:. Prevention. Keeping those with diabetes healthy.
-
The Chinese diabetes challenge
Novo Nordisk has also placed great emphasis on physician training in diabetes, focusing on prevention, screening, optimising treatment and patient communication. ... Another leading player in China in the diabetes sector, Bayer, has also placed emphasis
-
Interview: Peter Meeus, Novo Nordisk
Whatever they do to raise awareness of diabetes in terms of prevention, diagnosis and treatment we are also supporting.”. ... This can be a diabetes clinic or a programme to support diabetes footcare for example.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest appointments
-
New hires at bluebird bio, BioNTech and Provention Bio
In his role as CCO at Provention, Hoitt will be responsible for the development and execution of the company’s global commercial strategy for its type 1 diabetes prevention immunotherapy ... one diabetes (T1D) patients and at-risk individuals and, in
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Improving Public Health Through Telemedicine
Laurence Girard, CEO of Fruit Street Health, shares his tips for aspiring HealthTech entrepreneurs, his views on the future of telemedicine and digital health, and why he thinks healthcare companies should be funded by healthcare professionals
-
A new vision for tackling key illnesses
Diabetes. The NHS plans to double the size of the NHS Diabetes Prevention Programme for type 2 diabetes. ... The Long-term Plan shows how technology will help to move diabetes services out of hospitals and support self-care.
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- MHRA to introduce new UK clinical trials framework
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- 2023 PM Society Awards – winners announced
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Amgen gets block on sales of Repatha rival in Germany
- Congress is in session – how companies are boosting their impact and engagement
- The state of pharma customer experience
PMHub
Purple Agency
An Integrated Marketing Communications Agency with a passion for Intelligent Strategy, Compelling Creativity and Professional Delivery....
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
